ConductScience.org, home

Paper17548745

Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

Heinrichs RW. Arch Gen Psychiatry, 2007. Cited by 37 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Papers, record 17548745. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17548745

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
PubMed
Journal
Arch Gen Psychiatry
PubMed
Year
2007
PubMed
Publication types
Comment, Journal Article
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
1.09
iCite
Revised in PubMed
2007-11-15
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Heinrichs RWR Walter

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antipsychotic AgentsMajor topic
Cognition DisordersMajor topic
Neuropsychological TestsMajor topic
SchizophreniaMajor topic
Schizophrenic PsychologyMajor topic
Chronic Disease
Humans
Randomized Controlled Trials as Topic
Treatment Outcome

Source PubMed

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on17,548,746Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.https://conductscience.org/library/papers/17548746

Source PubMed

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
41,421,073Neighborhood environmental deprivation predicts the generalized neurocognitive deficit in schizophrenia.Schizophr Res2026https://conductscience.org/library/papers/41421073PubMed
40,860,664The effects of dance intervention on clinical symptoms and cognitive deficits in hospitalized patients with chronic schizophrenia: a randomized controlled trial.PeerJ2025https://conductscience.org/library/papers/40860664PubMed
40,545,821
Enhancement of the left frontoparietal network through real-time functional magnetic resonance imaging functional connectivity-informed neurofeedback and its impact on working memory in schizophrenia: A pilot study.
Psychiatry Clin Neurosci2025https://conductscience.org/library/papers/40545821PubMed
38,672,011The Effect of Antipsychotics on Cognition in Schizophrenia-A Current Narrative Review.Brain Sci2024https://conductscience.org/library/papers/38672011PubMed
37,881,571Medial Prefrontal Cortex Dysfunction Mediates Working Memory Deficits in Patients With Schizophrenia.Biol Psychiatry Glob Open Sci2023https://conductscience.org/library/papers/37881571PubMed
36,648,966Cognitive Rehabilitation in Schizophrenia-Associated Cognitive Impairment: A Review.Neurol Int2022https://conductscience.org/library/papers/36648966PubMed
33,692,676The Association Between Metabolic Disturbance and Cognitive Impairments in Early-Stage Schizophrenia.Front Hum Neurosci2020https://conductscience.org/library/papers/33692676PubMed
33,344,888Translation-Focused Approaches to GPCR Drug Discovery for Cognitive Impairments Associated with Schizophrenia.ACS Pharmacol Transl Sci2020https://conductscience.org/library/papers/33344888PubMed
32,655,348Subcortical Dopamine and Cognition in Schizophrenia: Looking Beyond Psychosis in Preclinical Models.Front Neurosci2020https://conductscience.org/library/papers/32655348PubMed
32,102,432N-(2-Hydroxyphenyl)-1-[3-(2-oxo-2,3-dihydro-1H- benzimidazol-1-yl)propyl]piperidine-4-Carboxamide (D2AAK4), a Multi-Target Ligand of Aminergic GPCRs, as a Potential Antipsychotic.Biomolecules2020https://conductscience.org/library/papers/32102432PubMed
30,568,606Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia.Front Psychiatry2018https://conductscience.org/library/papers/30568606PubMed
27,578,254Time-varying SMART design and data analysis methods for evaluating adaptive intervention effects.BMC Med Res Methodol2016https://conductscience.org/library/papers/27578254PubMed
27,039,372Interaction between COMT rs5993883 and second generation antipsychotics is linked to decreases in verbal cognition and cognitive control in bipolar disorder.BMC Psychol2016https://conductscience.org/library/papers/27039372PubMed
25,980,483Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study.Psychopharmacology (Berl)2015https://conductscience.org/library/papers/25980483PubMed
23,785,309Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development.Front Neurosci2013https://conductscience.org/library/papers/23785309PubMed
22,584,864Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.Mol Psychiatry2012https://conductscience.org/library/papers/22584864PubMed
22,336,800Antipsychotic drug treatment for elderly people with late-onset schizophrenia.Cochrane Database Syst Rev2012https://conductscience.org/library/papers/22336800PubMed
21,833,224Notes from Underground: Are Cognitive-Enhancing Drugs Respecting their Promises?Front Psychol2010https://conductscience.org/library/papers/21833224PubMed
21,726,569Mouse pharmacological models of cognitive disruption relevant to schizophrenia.Neuropharmacology2012https://conductscience.org/library/papers/21726569PubMed
19,821,380Ziprasidone versus other atypical antipsychotics for schizophrenia.Cochrane Database Syst Rev2009https://conductscience.org/library/papers/19821380PubMed

See all 21 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17548745

GET https://conductscience.org/api/papers/v1/17548745/cited_by?page=2